Exercise News and Research

Latest Exercise News and Research

Cell Therapeutics enters securities purchase agreement with single life sciences institutional investor

Cell Therapeutics enters securities purchase agreement with single life sciences institutional investor

ADVENTRX completes $22.5 million financing

ADVENTRX completes $22.5 million financing

Obesity in children today may contribute to 2-5 year decline in life expectancy

Obesity in children today may contribute to 2-5 year decline in life expectancy

NSAIDs raise risk of heart disease: Study

NSAIDs raise risk of heart disease: Study

Plenty of breaks from sitting at the desk are good for hearts and waistlines: Study

Plenty of breaks from sitting at the desk are good for hearts and waistlines: Study

5 easy steps to improve heart health

5 easy steps to improve heart health

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Amarin completes public offering at $7.60 per ADS

Amarin completes public offering at $7.60 per ADS

Race, ethnicity and geography influence colon cancer screening

Race, ethnicity and geography influence colon cancer screening

Bioheart announces primary focus on completing clinical evaluation of cell therapies for heart failure

Bioheart announces primary focus on completing clinical evaluation of cell therapies for heart failure

European CE Mark approval for IntraPace's abiliti system

European CE Mark approval for IntraPace's abiliti system

Health centers should screen students for depression

Health centers should screen students for depression

ACADIA raises $15 million through private placement

ACADIA raises $15 million through private placement

Innovative device reduces dental drill's noise, helps people to seek oral healthcare treatment

Innovative device reduces dental drill's noise, helps people to seek oral healthcare treatment

CORE Health Centers is now Inspire Health

CORE Health Centers is now Inspire Health

Underwriters exercise over-allotment option in Amarin ADS public offering

Underwriters exercise over-allotment option in Amarin ADS public offering

FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

ASBP raises concern over FDA recommendations to lower BMI requirements for lap-band surgery

ASBP raises concern over FDA recommendations to lower BMI requirements for lap-band surgery

ADVENTRX Pharmaceuticals to raise $22.5 million

ADVENTRX Pharmaceuticals to raise $22.5 million

Regular blood test shows pre-diabetes risk factors, reduces treatment costs

Regular blood test shows pre-diabetes risk factors, reduces treatment costs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.